Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed copies of advertisement of Postal Ballot Notice of the Company published on 13th January 2024, in Business Standard and Sakal newspapers. Sanofi India Ltd - 500674 - Compliances - Compliance Certificate For The Period Ended 31St December 2023.
Pursuant to Regulation 7(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed the compliance certificate for the year ended 31st December 2023. Sanofi India Ltd - 500674 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company has provided the enclosed certificate for the year ended 31st December 2023 under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. Request you to take the above certificate on record. Sanofi India Ltd - 500674 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Please find enclosed the calendar of events for the Postal Ballot process for your reference. We have also enclosed a copy of Postal Ballot Notice together with the Explanatory Statement for your record. Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Change in Management
Appointment of a Senior Management, refer enclosed file for details. Sanofi India Ltd - 500674 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanySanofi India Ltd 2CIN NO.L24239MH1956PLC009794 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Radhika Shah Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Rachid Ayari Designation: Wholetime Director and Chief Financial Officer EmailId: [email protected] Date: 08/01/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Sanofi India Ltd - 500674 - Announcement Under Regulation 30 (LODR)
Announcement under Regulation 30 (LODR) Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, we would like to inform you that the Company has approved issue of duplicate share certificates requests in lieu of the original share certificates reported lost/misplaced. Sanofi India appoints ex-Danone MD Himanshu Bakshi as head of its consumer healthcare business
Bakshi will be a member of Sanofi India's leadership team and senior management